Your Followed Topics

Top 2 conference on retroviruses and opportunistic infections News Today

#1
The war on science: resisting and rebuilding at a crucial juncture
#1 out of 2
health18h ago

The war on science: resisting and rebuilding at a crucial juncture

https://www.aidsmap.com/news/feb-2026/war-science-resisting-and-rebuilding-crucial-juncturehttps://www.eatg.org/hiv-news/croi-2026-aidsmap-the-war-on-science-resisting-and-rebuilding-at-a-crucial-juncture/
Aidsmap.com and 1 more
  • The 2025-2026 period is described as an ‘annus horribilis’ for HIV science and activism, signaling deep political and funding pressures that threaten progress.
  • Activists warn that cuts to funding, job losses, and political interference risk essential health programs like PEPFAR and USAID, amplifying health inequities.
  • The US government’s large-scale civil service cuts in healthcare agencies marked the largest reduction in the federal workforce to date, heightening health equity concerns.
  • Community and scientists have rebuilt alliances, turning science into a shared cultural framework that guides demands and activism.
  • Despite setbacks, NIH grants faced reinstatement and accelerated reviews after legal actions, signaling resilience in the funding landscape.
  • Activists advocate for strategic, mixed-action approaches, combining high-impact demonstrations with everyday mobilization to defend science.
  • Researchers report political pressure pushing some to scrub grant applications of terms like diversity and equity, signaling risk to inclusive science.
  • Stand Up for Science and allied groups mobilized to defend public health, emphasizing the value of reliable information as a form of activism.
  • Staley frames activism as historically linked to pivotal moments, suggesting a future rebound through renewed innovation and policy momentum.
  • The 2028 presidential landscape is being urged to include pledges to resurrect USAID and rebuild PEPFAR, tying election commitments to revival of core health programs.
Vote 1
0
#2
NIH-supported trial reduces HIV incidence by 70% in rural populations
#2 out of 2
health12h ago

NIH-supported trial reduces HIV incidence by 70% in rural populations

  • A NIH-supported trial in rural Kenya and Uganda reduced HIV incidence by 70% over two years using a multi-component intervention.
  • The intervention was implemented in 16 remote communities, with one community per pair receiving the enhanced program.
  • Home-based HIV testing by trained community health workers connected clients to care at local health centers.
  • Providers received training to deliver personalized, patient-centered HIV prevention and care.
  • An enhanced health app linked workers with clinicians and records to enable follow-up and prevention medication delivery.
  • HIV incidence reduction was consistent across age, sex, and country.
  • The study noted a four-fold increase in uptake of PrEP or PEP in the intervention communities.
  • Most health workers and participants found the intervention feasible to implement in real-world settings.
  • Researchers say the model could inform HIV prevention and care in other countries, including the United States.
  • The findings were presented at the 33rd Conference on Retroviruses and Opportunistic Infections in Denver.
Vote 0
0

Explore Your Interests

Unlimited Access
Personalized Feed
Full Experience
or
By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.

Explore Your Interests

Create an account and enjoy content that interests you with your personalized feed

Unlimited Access
Personalized Feed
Full Experience
or
By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.

Advertisement

Advertisement